학술논문

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
Document Type
journal article
Source
Journal of Infection; Oct2020, Vol. 81 Issue 4, pe11-e17, 7p
Subject
THERAPEUTIC use of monoclonal antibodies
VIRAL pneumonia
RESEARCH
RESEARCH methodology
COVID-19
ANTIVIRAL agents
CELL receptors
RETROSPECTIVE studies
EVALUATION research
MEDICAL cooperation
TREATMENT effectiveness
SEVERITY of illness index
COMPARATIVE studies
EPIDEMICS
HOSPITAL care
Language
ISSN
01634453
Abstract
Copyright of Journal of Infection is the property of W B Saunders and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)